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Astract
Background: Streptococcus suis serotype 2 (SS2), a major swine pathogen and an emerging zoonotic agent, has
greatly challenged global public health. Systematical information about host immune response to the infection is
important for understanding the molecular mechanism of diseases.
Results: 104 and 129 unique genes were significantly up-regulated and down-regulated in the spleens of pigs
infected with SS2 (WT). The up-regulated genes were principally related to immune response, such as genes
involved in inflammatory response; acute-phase/immune response; cell adhesion and response to stress. The
down-regulated genes were mainly involved in transcription, transport, material and energy metabolism which
were representative of the reduced vital activity of SS2-influenced cells. Only a few genes showed significantly
differential expression when comparing avirulent isogenic strain (ΔHP0197) with mock-infected samples.
Conclusions: Our findings indicated that highly pathogenic SS2 could persistently induce cytokines mainly by Toll-
like receptor 2 (TLR2) pathway, and the phagocytosis-resistant bacteria could induce high level of cytokines and
secrete toxins to destroy deep tissues, and cause meningitis, septicaemia, pneumonia, endocarditis, and arthritis.
Background
Streptococcus suis (S. suis) is an important pathogen
associated with many diseases in pigs, including menin-
gitis, septicaemia, pneumonia, endocarditis, and arthritis.
S. suis serotype 2 (SS2) is considered the most patho-
genic as well as the most prevalent capsular type among
thirty-three serotypes (types 1 to 31, 33, and 1/2) in dis-
eased pigs, and it is also the causative agent of serious
infections in humans, especially in people in close con-
tact with pig or pork byproducts [1-3]. Two recent
large-scale outbreaks of human SS2 epidemics in China
(one had 25 cases with 14 deaths in Jiangsu in 1998, the
second had 204 cases with 38 deaths in Sichuan in
2005), featured clinical streptococcal toxic shock syn-
drome, have greatly challenged the global public health
[4-7]. Recently, S. suis infection has also caused sporadic
human illness in other countries, including Thailand
[8,9], United Kingdom [10], Portugal [11], Australia
[12], Netherlands [13] and United States [14,15], and
been recognized as the third most common cause
of community acquired bacterial meningitis in Hong
Kong and as the leading cause of adult meningitis in
Vietnam [5,16].
The past pathogenesis studies were performed mainly
on the pathogenic bacteria and as a result, a few virulence-
associated factors have been successfully identified. Poly-
saccharide capsule has been considered essential for the
virulence of the bacterium [17,18], and other factors, such
as suilysin, the so-called extracellular protein factor and
muramidase-released protein have been shown to be
linked to, but not essential for the full virulence of S. suis
[19]. GapdH [20], Enolase [21,22], FbpS [19], Adhesin
[23-27] have been proved to be involved in the adherence
and virulence of S. suis. Recently, serum opacity-like factor
[28], IgA1 protease [29], D-Alanylation of Lipoteichoic
Acid [30] and pgdA [31] were identified as important fac-
tors in S. suis virulence. In addition, SalK/SalR [32] and
CovR [33] were found to affect the virulence of S. suis Chi-
nese isolates. These studies have contributed to the under-
standing of S. suis pathogenesis and also suggested that
host responses also play essential roles in the development
of the diseases.
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of the reasons why highly invasive SS2 strain could cause
severe diseases [31,34]. A few previous studies indicated
that high level of cytokines and chemokines could be
released by human brain microvascular endothelial cells
[35], a whole-blood culture system [36], macrophages
[37] and monocytes [38] stimulated by SS2, and have
important roles in the initiation and development of
inflammation and meningitis [39]. More direct proofs
were the studies on mice with different genetic back-
ground, which indicated that IL-10 was responsible, at
least in part, for the high survival, which suggested that
aberrant innate immune response contributed to SS2
diseases [40].
To be aware of the information about host immune
response would enable people to better understand the
disease. Transcriptional response of alveolar macro-
phages to SS2 has been performed and the results indi-
cated that NF-kB and MAP-kinases signaling pathways
were induced upon interaction with SS2 [41]. However,
it is not easy to get more information since the primary
macrophages are so sensitive to the interference. Spleen
plays an important role in immune response and could
be an ideal target to study host immune response
against infection [42,43]. In the present study, the gene
expression profiles of swine spleens which suffered from
highly pathogenic SS2, avirulent isogenic strain and PBS
respectively were investigated to reveal the host immune
response to SS2 and the contributions of host response
to SS2 diseases.
Results
Transcriptome analysis
The transcriptome analysis indicated that 14,992, 15,487
and 15,757 probe sets, corresponding to 62.1%, 64.2%
and 65.3% of all probe sets, were detected in WT,
ΔHP0197 and mock-infected pig spleens respectively
(Additional file 1). The expression profiles of porcine
spleens challenged with WT 3 days post inoculation
were compared with those of the mock-infected group.
After quantile normalization and statistical analysis,
1014 transcripts were identified at the global false dis-
covery rate (FDR) of 10% (Additional file 2). Further-
more, the criteria of a two-fold or greater change in
differential expression and a FDR of 10% were chosen
to determine up-regulated and down-regulated genes
in the WT infected replicates. Using these criteria, 120
and 132 transcripts, representing 104 and 129 unique
genes, were significantly up-regulated and down-
regulated respectively (Additional file 3). However, only
a few genes showed significantly differential expressions
when comparing ΔHP0197 with mock-infected samples
(Figure 1A).
Of the 233 unique DE transcripts, 158 transcripts could
be determined based on BLASTX searches and anno-
tated with DAVID or by searching against the GenBank
database (Figure 1B). Among these, 135 unique genes
were grouped into 39 categories based on biological pro-
cess Gene Ontology (GO) terms or according to their
potential Biology Process Classification by referring to
recent publications (Figure 1C). Unsurprisingly, the
majority of genes were related to the immune response,
Transcription, Transport, material and energy metabo-
lism, etc. (Table 1).
Validation of microarray data by quantitative real-time
PCR (qPCR)
The qPCR was performed to validate the expression pat-
terns during infection for specific genes identified in the
microarray assay. In order to validate the differential
expression of various identified genes, 16 up-regulated
genes, with the increase ranging from 2.0-fold to 18.6-
fold, and 3 down-regulated genes, with the decrease ran-
ging from 2.5-fold to 5.9-fold, were selected for qPCR
analysis. All the selected down-regulated genes could be
amplified from the control samples but failed to achieve
significant detectable signs from WT-infected spleens,
except for ALOX15 which showed 3.2-fold down-regu-
lated expression. All selected up-regulated genes showed
higher expression in WT-infected samples than in the
control samples (Table 2). Though variation in fold
changes could be observed between qPCR and microar-
ray (Table 2), the differential expression patterns were
coincident between the results of the two techniques,
which indicated the reliability of the microarray analysis.
Induction of inflammasomes and acute phase proteins by
SS2 infection
Highly pathogenic SS2 infection could cause up-regu-
lated expression of a large set of genes involved in the
inflammatory response and acute phase proteins by
microarray analysis. IL-1B, IL-6 and IL-8 could be
induced by foreign pathogens and play essential roles in
controlling infections [5,44]. However, they may also
cause pathology when these productions are excessive
or uncontrolled [45]. Ye et al. also found that signifi-
cantly high level of cytokines could be induced by highly
pathogenic SS2 strain and play important roles in sepsis
[34], which is in coincidence with ours. In addition,
quite a few genes related to inflammatory response were
found up-regulated, such as S100 family proteins
(S100A8, S100A9 and S100A12) [46], Pentraxin 3 [47]
and Resistin [48,49]. They play important roles in med-
iating inflammatory responses, recruiting inflammatory
cells to sites of tissue damage or contributing to resist-
ing the invasion of various pathogens.
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Page 2 of 12Acute phase proteins (APPs), such as Lactotransferrin
[50], Haptoglobin [51], Serum amyloid A 2 [52] and
coagulation factor XIII, were involved in physiologic
reactions initiated early in the inflammatory process
[53], and could be a response to S. suis infection [54].
CEBPD belonging to the CCAAT-enhancer binding pro-
tein (CEBP) family which is crucial in the regulation of
genes involved in immunity and inflammation. These
up-regulated genes are the representative of host acute
response struggling to eliminate invading pathogens.
Induction of genes related in cell adhesion and stress
response
Cell adhesion molecules (CAMs) have been implicated
in the regulation of a wide variety of fundamental cellu-
lar processes, such as cell adhesion, cell polarization,
survival, movement, and proliferation [55]. E-selectin is
a cell adhesion molecule expressed on endothelial cells
activated by cytokines, and plays an important role in
recruiting leukocytes to the site of injury [56]. Versican
can bind adhesion molecules on the surface of inflam-
matory leukocytes [57] and act as a TLR2 agonist in
inducing the release of proinflammatory cytokines [58].
Thrombospondin 1 is an adhesive glycoprotein that
mediates cell-to-cell and cell-to-matrix interactions and
it could interact with numerous proteases involved in
angiogenesis [59]. Mucosal vascular addressin cell adhe-
sion molecule 1 is predominantly expressed on high
endothelial venules in inflamed tissues, and could assist
the extravasations of leucocyte [60]. The up-regulation
of cell adhesion molecules after SS2 infection would
contribute to recruiting leukocytes to the site of infec-
tion, which could control infection.
Genes related to oxidative stress and homeostasis were
also identified to be up-regulated. SOD2 provides vital
protection against reactive oxygen species (ROS), thus
protecting tissues from damage in a broad range of dis-
ease states. The secretion of PGE2, together with nitric
Figure 1 Clustering and characterization of the differential expression of genes. (A) 233 genes were selected for cluster analysis which is
described in methods. Each row represents a separate transcript and each column represents a separate piglet. Color legend is on the left, the
color scale ranges from saturated green for log ratios -3.0 and above to saturate red for log ratios 3.0 and above. Red indicates increased
transcript expression levels, green indicates decreased levels compared with normal samples. (B) Percentage distribution of unique genes was
from 233 differentially regulated transcripts after BLASTX searches and annotation. 158 unique genes had significant similarities based on BLASTX
searches. 135(126+9) unique genes had been annotated by Biological Process (BP) Classification. (C) Categories of annotated genes genes based
on biological process GO term. Many categories shared the same transcripts.
Li et al. BMC Genomics 2010, 11:556
http://www.biomedcentral.com/1471-2164/11/556
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Function classification ENTREZ
GENE_ID
Description Fold
change
Q-value
(%)
Inflammatory response
929 CD14 Antigen 3.4 1.222
6279 S100 Calcium binding protein A8 19.3 1.508
6280 S100 Calcium binding protein A9 16.1 0
3588 Interleukin 10 receptor, beta 2.7 3.911
5743 Prostaglandin-Endoperoxide synthase 2 4.7 7.146
7057 Thrombospondin 1 2.4 6.387
3576 Interleukin 8 5.6 6.387
9547 Chemokine (C-X-C Motif) Ligand 14 2.0 8.898
6283 S100 Calcium binding protein A12 18.6 0
2908 Nuclear receptor subfamily 3, group C, member 1 0.5 6.882
6363 Chemokine (C-C Motif) Ligand 19 2.2 1.508
7097 Toll-like receptor 2 2.0 6.387
2920 Chemokine (C-X-C Motif) Ligand 2 7.3 3.385
246 Arachidonate 15-Lipoxygenase 0.2 2.181
7052 Transglutaminase 2 2.1 6.387
9332 CD163 antigen 11.7 0
6288 Serum amyloid A1 6.4 1.222
3553 Interleukin 1, beta 16.7 6.387
3569 Interleukin 6 (Interferon, Beta 2) 4.8 6.387
56729 Resistin 3.7 7.146
Response to stress
1153 Cold inducible rna binding protein 0.43 5.612
3320 Heat shock protein 90Kda alpha class A member 1 3.2 8.898
6916 Thromboxane A synthase 1 2.6 3.911
10963 Stress-induced-phosphoprotein 1 2.5 0
130872 AHA1, activator of heat shock 90Kda protein ATPase homolog 2 2.6 1.508
3337 Dnaj (Hsp40) homolog, subfamily B, member 1 2.8 1.222
871 Serpin peptidase inhibitor, clade H (Heat Shock Protein 47),
member 1
2.7 1.222
10808 Heat shock 105Kda/110Kda protein 1 3.3 0
3301 Dnaj (Hsp40) homolog, subfamily A, member 1 2.4 0
3304 Heat Shock 70Kda Protein 1A 11.1 0
Coagulation
5328 Plasminogen activator, urokinase 2.0 6.387
2162 Coagulationfactor XIII, A1 polypeptide 6.8 3.385
Signal transduction
9465 A kinase anchor protein 7 0.5 6.698
8519 Interferon induced transmembrane protein 1 2.0 6.387
115265 Dna-damage-inducible transcript 4-like 0.3 2.181
9770 Ras association (Ralgds/Af-6) domain family 2 2.4 6.387
9510 Adamm etallopeptidase with thrombospondin type 1 motif, 1 2.3 0
1363 Carboxypeptidase E 0.44 6.698
54210 Triggering receptor expressed on myeloid cells 1 3.2 6.387
9289 G protein-coupled receptor 56 0.46 6.698
7043 Transforming growth factor, beta 3 2.1 4.116
Transcription
2353 V-Fos fbj murine osteosarcoma viral oncogene homolog 2.8 3.911
84969 Chromosome 20 open reading frame 100 0.3 2.541
55885 Lim domain only 3 0.3 2.181
3726 Jun B proto-oncogene 2.6 7.146
91 Activin a receptor, type ib 3.4 1.222
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116448 Oligodendrocyte transcription factor 1 2.4 6.387
79365 Basic helix-loop-helix domain containing, class B, 3 0.4 2.181
64919 B-cell cll/lymphoma 11B 0.5 2.181
23635 Single-stranded dna binding protein 2 0.4 2.541
23414 Zinc finger protein, multitype 2 0.5 6.698
7552 Zinc finger protein 6 (Cmpx1) 0.5 3.385
6920 Transcription elongation factor A (SII), 3 2.2 6.387
4783 Nuclear factor, interleukin 3 regulated 2.4 3.911
1052 CCAAT/Enhancer binding protein (C/EBP), delta 3.1 0
Cell adhesion
6401 Selectin E 3.5 1.222
8174 Mucosal vascular addressin cell adhesion molecule 1 2.3 6.387
5067 Contactin 3 0.5 6.794
4867 Nephronophthisis 1 (Juvenile) 0.4 3.911
1462 Chondroitin sulfate proteoglycan 2 (Versican) 9.1 0
960 CD44 antigen 2.3 2.541
Ubiquitin cycle
115123 Membrane-associated ring finger (C3HC4) 3 4.4 1.222
7317 Ubiquitin-activating enzyme E1 0.4 2.181
11274 Ubiquitin specific peptidase 18 0.4 6.698
9666 Zinc finger daz interacting protein 3 0.5 6.882
Transport
6556 Solute carrier family 11, member 1 4.0 2.051
4057 Lactotransferrin 5.9 3.385
1356 Ceruloplasmin (Ferroxidase) 2.3 2.541
1410 Crystallin, alpha B 2.8 6.387
283652 Solute carrier family 24, member 5 0.4 2.181
54843 Synaptotagmin-like 2 0.4 6.698
6947 Haptocorrin 8.9 0
3949 Low density lipoprotein receptor 2.1 5.612
3043 Hemoglobin, beta 0.4 6.698
3042 Hemoglobin, alpha pseudogene 2 0.2 2.181
3040 Hemoglobin, alpha 1 0.2 2.181
2554 Gamma-aminobutyric acid (Gaba) a receptor, alpha 1 0.3 3.911
2288 Fk506 binding protein 4, 59Kda 2.2 1.222
6557 Solute carrier family 12, member 1 0.4 6.882
152789 Janus kinase and microtubule interacting protein 1 0.5 6.794
Nucleic acid metabolic process
401251 Muts homolog 5 0.5 6.698
56952 Phosphoribosyl transferase domain 0.4 2.181
51251 5’-Nucleotidase, cytosolic Iii 0.4 6.698
10492 Synaptotagmin binding, cytoplasmic rna interacting protein 0.4 4.116
8347 Histone 1,H2bd 2.6 6.387
8334 Histone 1, H2ac 5.6 1.222
6430 Splicing factor, arginine/serine-rich 5 0.5 0
4302 Myeloid/Lymphoid or mixed-lineage leukemia translocated to, 6 0.4 6.882
Response to stimulus
5806 Pentraxin-related gene, rapidly
induced by il-1 beta
14.1 1.222
6372 Chemokine (C-X-C motif) ligand 6 5.5 1.222
64135 Interferon induced with helicase c domain 1 0.4 6.698
3240 Haptoglobin 4.6 0
6648 Superoxide dismutase 2, mitochondrial 4.6 1.508
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1843 Dual specificity phosphatase 1 2.1 6.387
Cell differentiation/development
58189 Wap four-disulfide core domain 1 2.1 1.222
9531 Bcl2-associated athanogene 3 3.7 0
51454 Gulp, engulfment adaptor ptb domain containing1 0.4 2.181
212 Aminolevulinate, delta-, synthase 2 0.4 6.698
2012 Epithelial membrane protein 1 2.0 7.146
79689 Steap family member 4 2.8 3.911
9021 Suppressor of cytokine signaling 3 2.4 3.385
5270 Serpin peptidase inhibitor, clade E, member 2 2.3 3.385
1946 Ephrin-A5 0.4 3.911
85444 Leucine rich repeat and coiled-coil domain containing 1 0.5 5.612
54873 Palmdelphin 0.4 5.612
10439 Olfactomedin 1 3.3 6.387
Carbohydrate metabolic process
4199 Malic enzyme 1, NADP(+)-dependent, cytosolic 0.4 3.911
80760 Inter-alpha (Globulin) inhibitor H5 0.3 6.698
152831 Klotho beta 2.5 0
3101 Hexokinase 3 (White Cell) 2.9 6.387
3099 Hexokinase 2 2.3 8.898
1116 Chitinase 3-like 1 2.9 8.898
Protein metabolic process
85464 Slingshot homolog 2 2.3 1.508
51327 Erythroid associated factor 0.06 0
7076 Timp metallopeptidase inhibitor 1 4.4 1.222
7053 Transglutaminase 3 6.1 1.222
114907 F-box protein 32 0.4 6.794
64844 Membrane-associated ring finger (C3HC4) 7 0.5 2.181
64172 O-sialoglycoprotein endopeptidase-like 1 0.4 2.181
55466 Dnaj (Hsp40) homolog, subfamily A, member 4 2.7 2.541
51056 Leucine aminopeptidase 3 2.0 8.898
2289 Fk506 binding protein 5 2.5 6.387
26235 F-box and leucine-rich repeat protein 4 0.5 6.698
Nitrogen compound metabolic
process
383 Arginase 0.2 2.181
64850 Alanine-glyoxylate aminotransferase 2-like 1 0.2 6.882
6799 Sulfotransferase family, cytosolic, 1A, phenol-preferring, member
2
2.0 6.387
8974 Procollagen-proline, 2-oxoglutarate 4-dioxygenase, alpha
polypeptide ii
3.2 6.387
Others
129446 Cardiomyopathy associated 3 0.3 2.181
128218 Transmembrane protein 125 2.0 8.898
57763 Ankyrin repeat, family A, 2 0.4 2.181
29970 Schwannomin interacting protein 1 0.5 6.794
23336 Desmuslin 0.5 6.882
590 Butyrylcholinesterase 0.5 4.116
84649 Diacylglycerol o-acyltransferase homolog 2 3.2 1.222
79887 Hypothetical protein Flj22662 3.5 6.387
DE genes which putative functions assigned based on GO term and manual annotation. Manual annotations were listed in italics. Many genes with multiple
functions were only listed in one category according to specific biology processes. “FC≥2” represents up regulation (infection/control), “FC ≤ 0.5” represents
down regulation.
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Page 6 of 12oxide production, is involved in disruption of the blood-
brain barrier(BBB) in an experimental model of bacterial
meningitis [61]. S. suis-mediated PGE2 production by
human macrophages was also noticed by Jobin and con-
tributed to the BBB disruption [62].
Toll-like receptors (TLRs) pathway analysis
A c t i v a t i o no ft h ei n n a t ei m m u n er e s p o n s ei sc o n t r o l l e d
in large part by the Toll-like receptor (TLR) family of
pattern-recognition receptors. The previous study
showed that S. suis was mainly recognized via TLR2 by
THP-1 monocytes, which was associated with CD14
[38] and led to the release of pro-inflammatory media-
tors [63]. The strong activation of TLR2 and CD14 was
also observed in murine brain parenchyma after the pre-
sence of S. suis bacteremia [39]. A recent research indi-
cated that components released during S. suis infection
as well as penicillin-treated whole bacteria could induce
NF-kB activation through TLR2/6 [64]. The obvious ele-
vation of TLR2 (2.0 fold) and CD14 (3.4 fold) was
noticed at transcript level in spleens after highly patho-
genic SS2 infection. Unsurprisingly, MyD88, an adaptor
molecule in downstream signaling events with TLRs
and CD14, was up-regulated at the level of 1.5 fold
(q < 10%). In contrast, the effect could not be seen with
avirulent SS2 infection.
Down-regulated transcripts following S. suis infection
The majority of down-regulated genes were related to
transcription, transport, material and energy metabolism
(Table 1). Highly pathogenic strain could show high
level of toxicity to host cells [34], and as a result, the
influenced cells could hardly to be active. So these down
regulations could be regarded the representative of the
reduced vital activity of SS2-influenced cells.
Discussion
Two recent SS2 outbreaks in China not only seriously
challenged public health but also shocked the scientific
community, calling for the basic and translational stu-
dies of S. suis. Until now, several proteins were identi-
fied as vaccine candidates [65,66] and drug targets
[67,68] for controlling SS2. In addition, emphasis is also
extended to the pathogenesis study. Several pathogenic
factors were successfully identified and strengthened the
understanding for the virulence of the bacterium. As
infectious disease resulted from the interplay between
pathogens and the defense of the hosts they infect, host
immune response was especially essential for under-
standing the diseases [41,69].
In the present study, we tried to compare the gene
expression profiles of spleens from swine suffering from
highly pathogenic SS2, from swine infected with the
avirulent isogenic strain, and from swine inoculated with
PBS respectively to reveal the host immune response to
SS2 and the contributions of host response to SS2 dis-
eases. It is not accidental that significant changes of gene
expression profiles could be noticed when infected with
highly pathogenic SS2 compared with mock-infected
samples, while avirulent isogenic strain would cause simi-
lar profiles to mock-infected samples (Figure 1A). These
indicated that avirulent isogenic strain could hardly cause
significant gene expression which was coincident with
the fact that no significant clinical symptoms could be
noticed in pigs. Moreover, the obvious changes in gene
expression profiles were highly associated with significant
clinical signs on day 3 post-inoculation with highly
pathogenic strain. Further analysis of the present study
indicated that the majority of down-regulated genes were
mainly involved in transcription, transport, material and
energy metabolism which were representative of the
reduced vital activity of SS2-influenced cells. However,
the up-regulated genes were principally related to
immune response, such as genes involved in inflamma-
tory response; acute-phase/immune response; cell adhe-
sion and response to stress. Undoubtedly, it would
be meaningful to explore the roles of these genes in SS2-
caused diseases.
First of all, it is necessary to know how SS2 induces
immune response. It is well acknowledged that TLRs
are transmembrane proteins that could recognize speci-
fic PAMPs and eventually result in the activation of NF-
kB and MAP kinases to elicit regulatory response [70].
Among these transmembrane proteins, TLR-2 could
recognize bacterial LAM, BLP and PGN by following
their initial interaction with CD14. Previous reports
indicated that S. suis mainly induced proinflammatory
Table 2 Validation of microarray results by qPCR
Gene Accession Microarray fold
change
qPCR fold change
(p-value)
IL1B CK468468 16.7 258.3 (0.0117)
S100A9 BI402402 16.1 137.2 (0.0007)
S100A12 CB475695 18.6 76.7 (<0.0001)
HSP90 CF180819 3.18 48.5 (0.0321)
IL8 NM_213867 5.58 35.5 (0.0066)
HSP70 NM_213766 11.06 31.4 (0.0099)
TIMP1 NM_213857 4.4 14.6 (0.0023)
IL6 AF493992 4.8 10.5 (0.0074)
SOD2 NM_214127 4.6 10.0 (<0.0001)
NRAMP1 U55068 3.97 7.2 (0.0035)
SELE NM_214268 3.5 5.9 (0.0002)
PLAU NM_213945 2.0 5.5 (0.0415)
CCL19 BX672579 2.16 4.2 (0.0004)
haptocorrin CB472702 3.78 2.1 (0.0388)
TLR-2 NM_213761 2.0 2.1 (<0.0001)
ALOX15 NM_213931 0.2 0.3 (0.038)
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Page 7 of 12cytokines by TLR2 of human macrophages and murine
brain [39,63], and several proinflammatory cytokines,
such as IL-1B, IL-6, IL-8, TNF-a and MCP-1 could be
triggered [35,36,38,41]. In our study, large doses of bac-
teria could be isolated from spleens of WT-infected pigs
while no bacterium could be found to exist in pigs
infected with ΔHP0197. In coincidence with these, TLR-
2 pathway and several proinflammatory cytokines were
induced only in WT-infected pigs. ΔHP0197 showed
similar transcript profile as control pigs due to either
failing to invading or being easily eliminated by host. In
contrast, the large doses of bacteria effected maximal
cytokines release in WT-infected pigs [37]. The exagger-
ated high levels of cytokines perhaps exacerbate the
inflammation and were considered to be responsible for
S. suis caused diseases [39]. So the successful lethal
pathogens could persistently induce cytokines secreted
originally to clear the foreign invader, and as a result,
the host’s defense was utilized by S. suis to cause dis-
eases, and to some extent to death.
As we all know that the secreted cytokine is an impor-
tant part of a host defense system, which could recruit
inflammatory cells to sites of tissue damage and help to
eliminate the pathogens. However, this innate defense
system is a double edged sword. If the recruiting inflam-
matory cells could kill the invader, the disease could be
controlled. On the opposite side, if the recruiting phago-
cytes could not efficiently kill the bacteria, the tide
would be turned to pathogen’s favor, and the persis-
tently induced cytokines would result in the exacerbated
inflammation and lead to the death during the septic
phase of infection. These might be the reason why the
survival rate could be elevated when inflammation was
inhibited by IL-10 [40], and why the level of cytokine
was correlated inversely with survival time in patients
with sepsis [45]. In coincidence with our analysis, patho-
genic S. suis could effectively resist the uptake by phago-
cytes and CPS could inhibit activation of signaling
pathways involved in phagocytosis [17,71,72]. In addi-
tion, several virulence-associated proteins such as FBPS
[19], PDGA [31], LTA [30], HP0197 (unpublished data),
serine protease [73] etc. were also contributed to the
phagocytosis resistance, and the up-regulation of these
proteins in vivo may suggest the better phagocytosis
resistance [31,74,75]. Due to failing phagocytosis, bac-
teria could not only cause exacerbated inflammation but
also contribute to its survival in the bloodstream in
“modified Trojan Horse” theory in which bacteria travel
extracellularly while attached to, but not phagocytosed
[17,72], and then cause bacteremia and even septemia.
One of the key questions to be answered is how
S. suis crosses the blood-brain barrier to cause meningi-
tis, which was observed in all WT-infected pigs. The
findings of the reported study presented that suilysin-
positive strain could show toxin to produce functional
alteration and increase the permeability of BBB; and Sui-
lysin-negative strain might stimulate the production of
proinflammatory cytokines resulting in alteration of BBB
permeability [76,77]. And they also indicated that this
highly pathogenic strain could produce high level of tox-
ins in vivo-Suilysin, MRP, hyl [74], and undoubtedly it
would contribute to the penetration of deep tissue and
BBB. In addition, the stimulated production of proin-
flammatory cytokines would result in the alteration of
BBB permeability, and it would be more feasible for
S. suis to break through BBB. From our understanding,
WT strain could utilize the synergic effect of toxins and
high level of cytokines to accelerate the penetration of
deep tissue and BBB. These might be the reason why
the strain could cause severe human diseases in Sichuan,
2005.
Conclusions
Microarray technology has been used to analyse the
globle porcine transcriptional response to infection with
various pathogenic microorganisms recently. Study
on the transcriptional response to the Gram-positive
bacterium SS2 by using the Affymetrix GeneChip Porcine
Genome Array has not been reported until now.
Although great efforts have been made to understand the
molecular basis of this infection, the response to SS2
infection is still largely unknown. Transcriptome analysis
based on S. suis-infected spleens could improved the
interference received by the cells analysis, and also supply
the solid supplementary for analysis on alveolar macro-
phages. Highly pathogenic S. suis could persistently
induce cytokines mainly by TLR2 pathway, and even-
tually the high level of cytokines and toxins secreted by
phagocytosis-resistant bacteria could destroy deep tis-
sues, and cause meningitis, septicaemia, pneumonia,
endocarditis, and arthritis.
Methods
Bacterial strains
S S 2s t r a i n0 5 Z Y( W T )w h i c hw a si s o l a t e df r o mt h e
brain of a diseased piglet collected in Sichuan outbreak
in China 2005 showed high virulence to pigs [4,78], and
w a sa p p l i e dt oi n f e c tp i g s .A ni s o g e n i cHP0197 mutant
(ΔHP0197) derived strain 05ZY showed no obvious
virulence to pigs (unpublished data) was applied as a
control.
Animals infection and tissue collection
All the experimental protocols were approved by the
Laboratory Animal Monitoring Committee of Hubei
Province and performed accordingly. A total of 12 pigs
of high-health status (ages 4-5 weeks) were assigned
to three groups, within four in each. The pigs were
Li et al. BMC Genomics 2010, 11:556
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Page 8 of 12determined to be SS2-free by antibody-based ELISA and
nasal swabs-based bacteriologic test. One hour before
inoculation, all pigs were given 2 ml of 1% acetic acid
(pH 2.9) intranasally to enhance the sensitivity of the
S. suis challenge. Two groups were inoculated intrana-
sally with 1 ml of 2×10
6CFU of WT strain or ΔHP0197
respectively, and the rest group inoculated with PBS was
served as control. All pigs inoculated with WT showed
typical symptoms at day 3 while pigs inoculated with
ΔHP0197 or PBS showed no significant clinical signs.
Blood samples from each group were detected for bac-
terial burden. Bacteria could be found in the blood of
pigs in the WT group at day 3 post-inoculation while
no bacterium was found from the blood of pigs inocu-
lated with isogenic mutant strain or PBS at the same
time point. All pigs were sacrificed at day 3, and their
tissue samples were cultured to prove in vivo bacterial
burden. Bacteria were found in the spleens of the WT
group, and no bacterium was found in the other two
groups. Spleen samples were aseptically collected and
immediately frozen in liquid nitrogen for future RNA
isolation. Total RNA was isolated from approximately
200 mg of each sample by using the TRIzol (Invitrogen)
and RNeasy Midi kit (QIAGEN) based on the manufac-
turer’s protocols. The integrity, quality, and quantity of
RNA were assessed using the Agilent Bioanalyser 2100.
Microarray hybridizations and data analysis
The RNA labelling and hybridization were conducted by
a commercial Affymetrix array service (CapitalBio Corp.
Beijing, China). An aliquot of 2 μg of total RNA was
converted to double-stranded cDNA with the one-cycle
cDNA Synthesis Kit (Affymetrix), and then biotin-tagged
cRNA was produced with MessageAmp™ II aRNA
Amplification Kit. The resulting bio-tagged cRNA was
fragmented to strands of 35 to 200 bases in length
Table 3 Primers for qPCR
primer Accession
number
Sequence Product
size
Plau NM_213945 Forward: CGAACTGTGGCTGTCT
Reverse: AGCAGGTTTGCGATGTG
126 bp
S100A9
a BI402402 Forward: CCAGGATGTGGTTTATGGCTTTC
Reverse: CGGACCAAATGTCGCAGA
186 bp
S100A12
a CB475695 Forward: GGCATTATGACACCCTTATC
Reverse: GTCACCAGGACCACGAAT
169 bp
Hsp70 NM_213766 Forward: AGGCGGAGAAGTACAAAGCG
Reverse: GATGGGGTTACACACCTGCTC
257 bp
Timp1 NM_213857 Forward: CGCCTCGTACCAGCGTTAT
Reverse: GTGGAAGTATCCGCAGACGC
127 bp
SOD2 NM_214127 Forward: TCTGGACAAATCTGAGCCCT
Reverse: GACGGATACAGCGGTCAACTT
119 bp
Il6
b AF493992 Forward: GACAAAGCCACCACCCCTAA
Reverse: CTCGTTCTGTGACTGCAGCTTATC
69 bp
Sele NM_214268 Forward: GGATTTGAACTCATCGGACCT
Reverse: CATTCTGAGGATGGCCGAC
115 bp
Il1b
b NM_214055 Forward: GGCCGCCAAGATATAACTGA
Reverse: GGACCTCTGGGTATGGCTTTC
70 bp
Nramp1 U55068 Forward: CGTGGTGACAGGCAAGGACT
Reverse: TAGCCGTGCCGATGACTTC
131 bp
Hsp90 CF180819 Forward: CCCAGTTGATGTCGTTG
Reverse: CCGTCAGGCTTTCGTAT
117 bp
Il8
b NM_213867 Forward: TTCGATGCCAGTGCATAAATA
Reverse: CTGTACAACCTTCTGCACCCA
176 bp
CCL19 BX672579 Forward: GCTAAGCCTCTGGACT
Reverse: AATGAGCAGGTAGCGA
121 bp
Haptocorrin CB472702 Forward: ATTCTCAGGGAGTATTCCGTCT
Reverse: CTTTGGGGACAAGTAGCAGTT
105 bp
Alox15 NM_213931 Forward: ACCGAGGGTTTCCTGTCT
Reverse: AGGTGGTTGGAGGAGTGC
100 bp
TLR2
b NM_213761 Forward:TCACTTGTCTAACTTATCATCCTCTTG
Reverse: TCAGCGAAGGTGTCATTATTGC
162 bp
GAPDH
b AF017079 Forward: TGCCAACGTGTCGGTTGT
Reverse: TGTCATCATATTTGGCAGGTTTCT
62 bp
a: primers from reference [43];
b: primers from reference [41].
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hybridized to GeneChip Porcine Genome Array. Hybri-
dization was performed at 45°C with rotation for 16 h
(Affymetrix GeneChip Hybridization Oven 640). The
GeneChip arrays were washed and then stained (strepta-
vidin-phycoerythrin) on an Affymetrix Fluidics Station
450 followed by scanning on GeneChip Scanner 3000.
The hybridization data were analyzed using GeneChip
Operating software (GCOS 1.4). A global scaling factor of
500 was used to normalize the different arrays. We identi-
fied the differentially expressed genes according to change
p-value calculated by GCOS 1.4, and 2-fold change as an
empirical criterion. Then all DE genes were performed for
hierarchical cluster (Ver.3.0) and TreeView (Ver.1.1.1)
analyses. Genes with significant similarities to transcripts
in nr database based on BLASTX searches were selected
for GO analysis with DAVID http://david.abcc.ncifcrf.gov/
home.jsp. Annotation results were obtained by inputting
t h eg e n el i s to fE N T R E Z _ G E N E _ I Da si d e n t i f i e r .A l l
microarray results from this study were deposited in
NCBI’s Gene Expression Omnibus (GEO) database, acces-
sion numbers are: Platform, GPL3533; Series, GSE23596;
Samples, GSM578704, GSM578705, GSM578706,
GSM578707, GSM578708, GSM578709, GSM578710,
GSM578711, GSM578712.
qPCR analysis
All tested RNAs from swine spleens were reversely tran-
scribed to cDNA with the M-MLV Reverse Transcrip-
tase (Promega). Each cDNA sample was used as a
template for qPCR and the amplification mixture con-
tained SYBR Green (TOYOBO, Japan), forward and
reverse primers. Some primers were designed by the
program Primer 5.0, the primer names, accession num-
ber, primer sequence and product size are shown in
Table 3. The efficiency of the PCR reaction was 91-99%
for all reactions (slope standard line between -3.3 and
-3.6). The standard line consisted of five 10-fold dilu-
tions of the samples. Analysis was performed using the
ABI7500 Software (Applied Biosystems). PCRs were per-
formed in ABI PRISM 7500 sequence detection system
as follows: 1 cycle at 95°C for 10 min; 45 cycles at 95°C
for 30 s, 60°C for 30 s and 72°C for 30 s. Melting curves
w e r ep e r f o r m e da tt h ee n do fa m p l i f i c a t i o nf o rv a l i d a t -
ing data quality by increasing the temperature from 65°
C to 95°C, read every 0.2°C, hold 2 sec, then cooling at
25°C for 30 s. The PCR products were confirmed using
agarose gel electrophoresis (1.5%). Amplification of the
gapdh gene was used as internal control. All the tested
genes are shown in Table 3. All reactions were per-
formed in triplicate. For each run, to normalize the
amount of sample cDNA added to each reaction, the Ct
value of each test gene was subtracted by the Ct value
of the endogenous control gapdh gene (delta Ct = Ct
tested gene - Ct gapdh), and then for a comparison
between the expression of the gene in treated samples
and in control samples. The delta Ct values of the gene
in treated samples were subtracted by the delta Ct value
of the gene in control samples (delta-delta Ct = delta Ct
treatment - delta Ct control). The fold changes were cal-
c u l a t e db yt h ef o r m u l ao f2
-delta-delta Ct described by
Livak & Schmittgen [79]. Data were means ± SD of tri-
plicate reactions for each gene transcript.
Additional material
Additional file 1: Spleen transcriptome analysis following S. suis
infection using the Affymetrix Porcine Genechip. Data of each probe
is from the three piglets of the control group (NC-1P, NC-2P, NC-3P), the
WT group (WT-1P, WT-2P, WT-3P) and the △HP0197 group (M97-1P, M97-
2P, M97-3P). “P”, present; “A”, absent; “M”, marginal; select while Count (P)
≥ 2 in two groups. Totally, 15,757, 14,992 and 15,487 probesets were
detected expression in the control group, the WT group and △HP0197
group respectively.
Additional file 2: transcripts expressed in porcine spleen following
S. suis (WT) infection. “FC”, Fold change, gene expression level
following WT infection compared to the control. “≥2” represents up
regulation, “<1” represents down regulation. “q-value”, significance level
of differential expression for a particular gene. “Gene description”,t o p
informative BLASTX hit.
Additional file 3: Differentially expressed transcripts in porcine
spleen following S. suis (WT) infection (q < 10%, FC≥2).1 2 0
transcripts (row 5-124) were significantly up-regulated, and 132 (row 125-
256) were significantly down-regulated, “FC”, Fold change, gene
expression level following WT infection compared to the control.
Abbreviations
SS2: Streptococcus suis serotype 2; DE: differentially expressed; FC: fold
change; GO: Gene Ontology; FDR: false discovery rate; qPCR: quantitative
real-time PCR; TLR: Toll-like receptors; PRRs: pattern-recognition receptors.
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